跳至主要内容
临床试验/NCT03304899
NCT03304899Unknown1 期

Early Fibrinogen Concentrate in Isolated Traumatic Brain Injury and the Effect on Post Bleeding & Complications

Leila Dehghani1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年10月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
50
试验地点
1
主要终点
Mortality rate.

研究概览

简要总结

Fibrinogen is a unique precursor of fibrin and cannot be compensated for by other coagulation factors. If plasma fibrinogen concentrations are insufficient, hemostatic clots cannot be formed with the appropriate firmness. In severe traumatic brain injury(TBI) patients, plasma fibrinogen concentrations decrease earlier and more frequently than other coagulation factors,predicting massive bleeding and death.

The purpose of this study is to try early injection of fibrinogen concentrate in severe isolated traumatic brain injury and investigation the effect of it on post bleeding and complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with severe isolated traumatic brain injury.

排除标准

  • Severe abdomen or extremities trauma.
  • Severe bleeding from abdomen or extremities.
  • Congenital coagulopathy (Hemophilia, protein S and C deficiency, Factor 5 Leiden deficiency and ...).
  • Warfarin, Heparin, Enoxaparin, Dabigatran and other anticoagulation drugs consumption.

研究组 & 干预措施

Case group

Experimental

Severe isolated Traumatic Brain injury patients with serum fibrinogen level under 200 mg/dl that receive Fibrinogen concentrate after common emergency resuscitation. Instruction:

  1. Airway control & breathing.
  2. Circulation (Serum therapy, Epinephrine,Packed cell, FFP and ...).
  3. Fibrinogen Concentrate(IV injection): Each vial contains 1gr fibrinogen concentrate. Fibrinogen concentrate will be given until serum fibrinogen level riches to 200 mg/dl.

Dose (mg/kg body weight) = ([Target level (mg/dL) - measured level (mg/dL)])/(1.7 (mg/dL per mg/kg body weight))

干预措施: RiaSTAP Injectable Product (Drug)

Control group

Active Comparator

Severe isolated Traumatic Brain injury patients with serum fibrinogen level under 200 mg/dl that receive common emergency resuscitation. Instruction:

  1. Airway control & breathing.
  2. Circulation (Serum therapy, Epinephrine,Packed cell, FFP and ...).

干预措施: RiaSTAP Injectable Product (Drug)

结局指标

主要结局

Mortality rate.

时间窗: Until 90 days after admission.

Mortality rate after injection of fibrinogen concentrate.

Average of serum fibrinogen level.

时间窗: Immediately after admission.

Average of serum fibrinogen level in iTBI patient.

The effect of early fibrinogen on post trauma bleeding (Intracranial hemorrhage).

时间窗: 2, 6, 24, 72 hours and 30 , 90 days after admission.

The need to packed cell, FFP, Platelete.

次要结局

  • The complications that related to fibrinogen concentrate.(until 90 days after admission.)

研究者

发起方
Leila Dehghani
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Leila Dehghani

Early fibrinogen concentrate in severe isolated traumatic brain injury and the effect on post bleeding and complications.

Isfahan University of Medical Sciences

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Application of fibrinogen concentrate (Fibrinogen HT) to uncontrollable massive bleedingMassive bleeding during 1)Pregnancy and delivery 2)Cardiovascular surgery 3)Gastrointestinal (including hepato-biliary-pancreatic) surgery
JPRN-UMIN000022666Kagoshima University Hospital, Division of blood transfusion medicine and cell therapy26
已完成
不适用
Effect of prophylactic fibrinogen on the need for perioperative blood transfusion in traumatic patients undergoing abdominal surgeryInjury of intra-abdominal organs.Injury of intra-abdominal organs
IRCT2016050220795N3Tabriz University of Medical Sciences40
已完成
2 期
Pilot Randomized Trial of Fibrinogen in Trauma HaemorrhageTraumaHaemorrhage
NCT02344069Rigshospitalet, Denmark40
进行中(未招募)
1 期
Treatment to enhance the blood ability to clot in case of haemorrhage following child birthPostpartum blødningMedDRA version: 21.1Level: LLTClassification code 10036296Term: Postpartum haemorrhage NOSSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsMedDRA version: 21.1Level: LLTClassification code 10036294Term: Postpartum haemorrhage (primary)System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsMedDRA version: 21.1Level: LLTClassification code 10043454Term: Third-stage postpartum haemorrhageSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsMedDRA version: 20.1Level: PTClassification code 10036417Term: Postpartum haemorrhageSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsMedDRA version: 21.1Level: LLTClassification code 10055864Term: Other immediate postpartum haemorrhage, postpartumSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsMedDRA version: 21.1Level: PTClassification code 10043449Term: Third stage postpartum haemorrhageSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions
EUCTR2009-017736-41-DKAnæstesiologisk Afd. Herlev Hospital245
已完成
不适用
Effect of prophylactic fibrinogen on post operative bleeding in coronary artery bypass graft surgeryHemorrhage.Hemorrhage, not elsewhere classified
IRCT201011085140N1Tehran University of Medical Sciences60